UREIDOPENICILLINS AND BETA-LACTAM/BETA-LACTAMASE INHIBITOR COMBINATIONS
- 1 June 2000
- journal article
- review article
- Published by Elsevier in Infectious Disease Clinics of North America
- Vol. 14 (2) , 409-433
- https://doi.org/10.1016/s0891-5520(05)70255-5
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- Susceptibility of Anaerobic Bacteria to β-Lactam Antibiotics in the United StatesClinical Infectious Diseases, 1993
- Vancomycin, Ticarcillin, and Amikacin Compared with Ticarcillin-Clavulanate and Amikacin in the Empirical Treatment of Febrile, Neutropenic Children with CancerNew England Journal of Medicine, 1988
- Penetration of Sulbactam into the Cerebrospinal Fluid of Patients with Bacterial Meningitis Receiving Ampicillin TherapyClinical Infectious Diseases, 1986
- In Vitro Activity of Aminopenicillins Combined with Sulbactam, Clavulanic Acid, or Amdinocillin Against Bacteria Isolated from Patients with Complicated Urinary Tract InfectionsClinical Infectious Diseases, 1986
- Ticarcillin plus clavulanic acid versus cefoxitin in the prophylaxis of infection after cesarean sectionThe American Journal of Medicine, 1985
- Antibiotics in penetrating abdominal trauma: Comparison of ticarcillin plus clavulanic acid with gentamicin plus clindamycinThe American Journal of Medicine, 1985
- Safety and efficacy of ticarcillin plus clavulanic acid in the treatment of infections of soft tissue, bone, and jointThe American Journal of Medicine, 1985
- Piperacillin v Carbenicillin in the therapy for serious infectionsArchives of internal medicine (1960), 1982
- Piperacillin plus amikacin therapy v carbenicillin plus amikacin therapy in febrile, granulocytopenic patientsArchives of internal medicine (1960), 1982
- Piperacillin, a new penicillin with high anti-pseudomonal activityJournal of Antimicrobial Chemotherapy, 1978